Abstract
The hypothalamic tetradecapeptide, somatostatin (SRIF), inhibits the secretion of growth hormone (GH)1 and numerous other hormones2, including insulin and glucagon3,4. Attempts to use SRIF as an adjunct in the treatment of diabetes mellitus5,6 met with limited success due to its short biological half-life7,8 and the undesirable diabetogenic activity of its insulin-lowering properties3,9,10. Efforts at synthesis have yielded SRIF derivatives with prolonged GH-lowering activity which did not suppress glucagon or had equivalent insulin-inhibiting activity11–14 as well as several short-acting compounds with the appropriate glucagon specificity15,16. A dodecapeptide analogue [des-Ala1, Gly2] His4,5-D-Trp8-SRIF (Wy-41, 747) has been identified that combines selective inhibition of GH and glucagon release with prolonged activity17,18. However, in routine pharmacological tests chronic treatment of mature rats with Wy-41, 747 produced anti-reproductive effects resembling those described for luteinising hormone (LH)-releasing hormone (RH) and its agonists19–25. We report here that Wy-41, 747, unlike SRIF and other of its analogues tested, releases LH, induces ovulation and inhibits pregnancy when administered before or after implantation; these properties are traditionally associated with the separate LH-releasing class of peptides.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brazeau, P. et al. Science 179, 77–79 (1973).
Guillemin, R. & Gerich, J. E. A. Rev. Med. 27, 379–388 (1976).
Alberti, K. G. M. M. et al. Lancet ii, 1299–1301 (1973).
Gerich, J. E. et al. Diabetes 23, 876–880 (1974).
Unger, R. H. & Orci, L. Lancet i, 14–16 (1975).
Gerich, J. E. et al. New Engl. J. Med. 291, 544–547 (1974).
Brazeau, P., Rivier, J., Vale, W. & Guillemin, R. Endocrinology 94, 184–187 (1974).
Ensinck, J. W. et al. Clin. Res. 24, 155A (1976).
Lins, P. E. & Efendic, S. Horm. Metab. Res. 8, 497–498 (1976).
Waldhausl, W., Bratusch-Marrain, P., Dudczak, R. & Deutsch, E. J. clin. endocr. Metab. 44, 876–883 (1977).
Rivier, J., Brown, M. & Vale, W. Biochim. biophys. Res. Commun. 65, 746–751 (1975).
Sarantakis, D., Teichman, J., Lien, E. L. & Fenichel, R. L. Biochem. biophys. Res. Commun. 73, 336–342 (1976).
Lien, E. L. & Garsky, V. M. Endocrinology 103, 81–85 (1978).
Lien, E. L. et al. Biochem. biophys. Res. Commun. 77, 1317–1325 (1977).
Brown, M., Rivier, J. & Vale, W. Science 196, 1467–1469 (1977).
Meyers, C., et al. Biochem. biophys. Res. Commun. 74, 630–636 (1977).
Sarantakis, D., Teichman, J., Fenichel, R. & Lien, E. L. FEBS Lett. 92, 153–155 (1978).
Lien, E. L., Greenwood, J. & Sarantakis, D. Diabetes 28, 491–495 (1979).
Corbin, A. et al. Int. J. Fertil. 23, 81–92 (1978).
Corbin, A., Beattie, C. W., Jones, R. & Bex, F. Int. J. Gynaec. Obstet. 16, 359–372 (1979).
Bex, F. J. & Corbin, A. Endocrinology 105, 139–145 (1979).
Kledzik, G. S., Cusan, L., Auclair, C., Kelly, P. A. & Labrie, F. Fertil. Steril. 29, 560–564 (1978).
Auclair, C., Kelly, P. A., Labrie, F., Coy, D. H. & Schally, A. V. Biochem. biophys. Res. Commun. 76, 855–862 (1977).
Bex, F. J. & Corbin, A. Program 3rd Annual Meeting American Society of Andrology, Nashville 6 (1978).
Pelletier, G. et al. Endocrinology 103, 641–643 (1978).
Bartke, A., Steele, R. E., Musto, N. & Caldwell, B. V. Endocrinology 92, 1223–1228 (1973).
Hall, R. et al. Lancet ii, 581–584 (1973).
Siler, T. M. et al. J. clin. endocr. Metab. 37, 632–635 (1973).
Hsueh, A. J. W. & Erickson, G. F. Science 204, 854–855 (1979).
Ying, S-Y. & Guillemin, R. Nature 280, 593–595 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bex, F., Corbin, A., Sarantakis, D. et al. Luteinising hormone-releasing and anti-fertility properties of a glucagon-selective somatostatin analogue. Nature 284, 342–343 (1980). https://doi.org/10.1038/284342a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/284342a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.